Aktionärsstruktur der Mylan
Portrait der Mylan Aktie
Das Unternehmen Mylan aus USA ist in den Bereichen Chemie & Pharma, Pharma tätig.
Mylan ist in mehr als 35 ETFs enthalten und somit eine vermutlich durchschnittlich bekannte Aktie. Der Spitzenreiter VanEck Vectors Pharmaceutical ETF gewichtet Mylan mit 4,12% im ETF.
Entdecke die 6 ETFs in denen Mylan am höchsten gewichtet ist Insgesamt in 35 ETFs enthalten
Dir gefallen die Informationen zu Mylan?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Mylan?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Mylan?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Mylan?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
87 News & Informationen zur Mylan Aktie
3 Big Drug/Biotech Outperformers Worth Keeping an Eye On (Revised)
Stocks Analysis by Zacks Investment Research covering: Eli Lilly and Company, Biogen Inc, Pfizer Inc, Viatris Inc. Read Zacks Investment Research's latest article on Investing.com
Deerfield Management Company, L.p. (series C) Buys Singular Genomics Systems Inc, CareMax Inc, AdaptHealth Corp, Sells Boston Scientific Corp, , Biogen Inc
GuruFocus Article or News written by insider and the topic is about:
Miller Value Partners, Llc Buys Splunk Inc, Metromile Inc, SoFi Technologies Inc, Sells Workday Inc, Discovery Inc, Flexion Therapeutics Inc
GuruFocus Article or News written by insider and the topic is about:
Thompson Investment Management, Inc. Buys Viatris Inc, Discovery Inc, Kimberly-Clark Corp, Sells General Electric Co, Darden Restaurants Inc, Sysco Corp
GuruFocus Article or News written by insider and the topic is about:
Mittleman Investment Management, Llc Buys Viatris Inc
GuruFocus Article or News written by insider and the topic is about:
Fishman Jay A Ltd Buys Paysafe, AbbVie Inc, Bristol-Myers Squibb Company, Sells Macquarie Infrastructure Corp, Bausch Health Inc, Cisco Systems Inc
GuruFocus Article or News written by insider and the topic is about:
Jabodon Pt Co Buys Guidewire Software Inc, T-Mobile US Inc, Visa Inc, Sells Lightspeed Commerce Inc, Citigroup Inc, Microsoft Corp
GuruFocus Article or News written by insider and the topic is about:
Global Atopic Dermatitis Drugs Market Report 2021: Rising Incident of Food Allergies Intensifying Atopic Dermatitis – Forecast to 2026
DUBLIN, Aug. 19, 2021 /PRNewswire/ — The 'Global Atopic Dermatitis Drugs Market (2021-2026) by Drug Class, Route of Administration, Geography, Co…
Meyer Handelman Co Buys Travel+Leisure Co, TJX Inc, Salesforce.com Inc, Sells Travel+Leisure Co, Viatris Inc,
GuruFocus Article or News written by insider and the topic is about:
Pzena Investment Management LLC Buys NRG Energy Inc, Westinghouse Air Brake Technologies Corp, Exxon Mobil Corp, Sells Viatris Inc, Morgan Stanley, TCF Financial Corp
GuruFocus Article or News written by insider and the topic is about:
India Anti-Fungal Drugs Markets Report 2021: Historical Data 2017-2020, Base Year Of 2021, Estimates For 2022 & Forecasts 2023-2027
DUBLIN, Aug. 12, 2021 /PRNewswire/ — The “India Anti-Fungal Drugs Market, By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication,
Global Anaphylaxis Treatment Market Research Report 2021: Rise in Cases of Allergies Post Administration of COVID-19 Vaccines
/PRNewswire/ — The “Anaphylaxis Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Medication Type, Route of Administration, Allergy…
Viatris Inc. (VTRS) CEO Michael Goettler on Q2 2021 Results – Earnings Call Transcript
Viatris Inc. (NASDAQ:VTRS) Q2 2021 Earnings Conference Call August 09, 2021, 10:00 AM ET Company Participants Melissa Trombetta – Head, Global IR Michael Goettler – CEO Rajiv Malik -…
Viatris Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:VTRS)
The following slide deck was published by Viatris Inc.
Viatris (VTRS) Beats on Q2 Earnings & Sales, Raises View
Viatris (VTRS) beats on Q2 earnings and sales. The company raises annual guidance.
Viatris (NASDAQ:VTRS): What Lies Ahead After Q2 Results?
Viatris (VTRS) delivered good Q2-2021 results. See what lies ahead for Viatris after its Q2 results. Find out if we changed our earlier Neutral view on Viatris stock.
Viatris raises 2021 guidance as quarterly revenue improves (NASDAQ:VTRS)
Viatris (VTRS) was trading ~4.6% higher in the pre-market after the company raised its 2021 guidance following an improvement in quarterly revenue generation.In Q2 2021, Viatris…
Viatris Boosts FY21 Revenue Outlook, Declares Dividend – Quick Facts
While reporting financial results for the second quarter on Monday, healthcare company Viatris Inc. (VTRS) raised its total revenue guidance for the full-year 2021.
Viatris Earnings Miss, Revenue Beats In Q2 By Investing.com
Viatris Earnings Miss, Revenue Beats In Q2
EARNINGS SUMMARY: Details of Viatris Inc. Q2 Earnings Report
(RTTNews) – Below are the earnings highlights for Viatris Inc. (VTRS): -Earnings: -$279.2 million in Q2 vs. $39.4 million in the same period last…
Viatris EPS beats by $0.10, beats on revenue, raises guidance (NASDAQ:VTRS)
Viatris (VTRS): Q2 Non-GAAP EPS of $0.98 beats by $0.10; GAAP EPS of -$0.23 misses by $0.45.Revenue of $4.58B (+67.8% Y/Y) beats by $180M.Updates 2021 Financial Guidance (1) – Raises…
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of …
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnin…
All of Wall Street’s pandemic weirdness is about to be on display
Wall Street has gotten weird during the COVID-19 pandemic, and all of that weirdness is about to be on full display.
Viatris (VTRS) Outpaces Stock Market Gains: What You Should Know
Viatris (VTRS) closed the most recent trading day at $13.92, moving +1.13% from the previous trading session.
Viatris (VTRS) Outpaces Stock Market Gains: What You Should Know
Viatris (VTRS) closed the most recent trading day at $13.92, moving +1.13% from the previous trading session.
Global Depression Treatment Market (2020 to 2026) – Featuring Allergen, Bausch Health Companies and Lief Therapeutics Among Others
/PRNewswire/ — The
Global Depression Treatment Market (2020 To 2026) – Featuring Allergen, Bausch Health Companies And Lief Therapeutics Among Others
DUBLIN, Aug. 5, 2021 /PRNewswire/ — The
Viatris (VTRS) to Report Q2 Earnings: What's in the Cards?
Investors will look forward to regular top and bottom-line numbers and updates on the merger synergies when Viatris (VTRS) reports Q2 results.
Is Viatris a Winner in the Pharmaceuticals Industry? By StockNews
Is Viatris a Winner in the Pharmaceuticals Industry?
FDA Lets Pharmacies Substitute Branded Insulin With Knockoff Product, in First for a Biologic Drug
For the first time, U.S. regulators have said that a biosimilar version of a biologic drug is interchangeable with its branded equivalent.
Essex Savings Bank Buys Verisk Analytics Inc, BlackRock Inc, Citigroup Inc, Sells iShares National Muni Bond ETF, iShares Gold Trust, GlaxoSmithKline PLC
GuruFocus Article or News written by insider and the topic is about:
U.S. FDA approves Biocon’s insulin Semglee
Biocon Biologics and Viatris Inc said the U.S. Food and Drug Administration (FDA) had approved Semglee®, a long-acting insulin injection, as the first interchangeable biosimilar product for the treatm
USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug
Read more about USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug on Business Standard. Semglee may now be substituted for Sanofi's Lantus by a pharmacist in the US
Viatris Gets FDA Approval For Interchangeable Biosimilar Semglee For Diabetes Treatment
(RTTNews) – Viatris Inc. (VTRS) and Biocon Biologics said that they received an approval from the U.S. Food and Drug Administration for the first …
The Real Value Of Viatris Stock (NASDAQ:VTRS)
Short-term uncertainties mask Viatris's long-term upside potential. This stock looks good. Shares have 40% upside today and become even more attractive as the price drops.
Global Polycythemia Vera Therapeutics Market to Surpass US$ 1,516.5 Million by 2028, Says Coherent Market Insights (CMI)
SEATTLE, July 27, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global polycythemia vera therapeutics market is estimated to be…
Mylan Wins Dismissal of Kansas EpiPen® Direct Purchaser Case
/PRNewswire/ — Viatris (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas granted Mylan's motion to dismiss in a lawsuit…
Sippican Capital Adivsors Buys Lockheed Martin Corp, Viatris Inc, Textron Inc, Sells Micron Technology Inc
GuruFocus Article or News written by insider and the topic is about:
DORCHESTER WEALTH MANAGEMENT Co Buys Viatris Inc, JOFF Fintech Acquisition Corp, TELUS International (Cda) Inc, Sells Canadian Pacific Railway, ESS U.S.Global Jets ETF, Teladoc Health Inc
GuruFocus Article or News written by insider and the topic is about: